Geneesmiddelenbeleid

This motion concerns the national pharmaceutical policy of the Netherlands. It aims to address how medicines are managed, priced, or accessed within the healthcare system to ensure sustainable and effective patient care. This procedure primarily affects healthcare providers, pharmaceutical companies, and patients who rely on the availability and affordability of essential medicines.